{"status": "Ok", "redirect_url": "https://www.equilliumbio.com/investors/events-and-presentations/event-details/2022/Equillium-and-Ono-Pharmaceuticals-Announce-Exclusive-Option-and-Asset-Purchase-Agreement-for-the-Development-and-Commercialization-of-Itolizumab/default.aspx", "message": "News view counter 14485 successfully enlarged"}